FEB 03, 2020 3:02 PM PST

HIV Viral Structures Improve Therapeutics

WRITTEN BY: Nouran Amin

Researchers have recently discovered how a powerful class of HIV drugs bind to a key piece of HIV machinery. Their findings, for the first time, shows how HIV therapy can be potent.

"The drugs we studied are the latest compounds available in the clinic today, as well as several important pre-clinical molecules. Until now, no one knew exactly how they bound to this HIV complex," says the study's senior author Dmitry Lyumkis, an assistant professor in Salk's Laboratory of Genetics. "A better understanding of how the drugs work will help us improve them and design new therapeutic compounds."

The intasome is a critical part of the HIV structure of which enables infection by integrating the virus’s genetic material into human DNA. This is why some drugs, called integrase strand transfer inhibitors (INSTIs), treat HIV by blocking the actions of intasome.

Even through these drugs were a success—scientists still struggled to examine how they inhibited the HIV intasome.

"To this day, everyone is still using the PFV intasome structure to rationalize and understand the mechanism of action of these drugs," says Dario Passos, the study's co-first author and a staff scientist in Lyumkis' laboratory. "But we've shown that the field really needs to move and study the HIV structure if we want to make further progress."

"We and many others have been working towards this goal for several decades and it is exciting that at long last we can now understand how HIV inhibitors work in detail and aid the development of new drugs." says Min Li, co-first author and a staff scientist at the National Institute of Diabetes and Digestive and Kidney Diseases.

In the study, researchers obtained the structure of HIV intasomes while they were being actively blocked by one of four INSTIs. They observed that a compound known as 4f has unique qualities in binding to HIV and thus can help improve the binding properties of potential future molecules.

"In previous structures, we learned about intasome biology," says Lyumkis. "But here, we've really started to gain insight into the therapeutic angle of how drugs can target these important viral assemblies."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 16, 2020
Neuroscience
MAY 16, 2020
Stem Cell Method (Parkinson's) Could Avoid Transplant Rejection
Researchers at McLean Hospital and Massachusetts General Hospital (MGH) have tested a stem cell treatment method that av ...
MAY 22, 2020
Drug Discovery & Development
MAY 22, 2020
Evaluating a Popular Diabetic Drug
A study by researchers at UT Southwestern study shows that a previous drug for Type 2 diabetes may be effective when pai ...
MAY 28, 2020
Cancer
MAY 28, 2020
The Oncogenic Hazard of a Potential Alzheimer's Treatment
Breast cancer remains one of the most common cancers around the world. Triple-Negative Breast Cancer (TNBC) is a sub-typ ...
JUN 04, 2020
Cannabis Sciences
JUN 04, 2020
Which is Better for Pain Relief: CBD or THC?
Cannabidiol (CBD) and tetrahydrocannabinol (THC) are the two most famous compounds in cannabis. While CBD is known for i ...
JUN 14, 2020
Chemistry & Physics
JUN 14, 2020
Why Are There So Few Black People in STEM?
On June 10th, 2020, thousands of STEM scientists and organizations around the world went on strike to protest systemic r ...
JUL 05, 2020
Drug Discovery & Development
JUL 05, 2020
New Drug May Reduce Inflammation from COVID-19
Scientists from the University of Toronto have identified a new drug candidate that may reduce all kinds of inflammation ...
Loading Comments...